TY - JOUR
AU - A. H. Talal
AU - S. J. George
AU - L. A. Talal
AU - A. Dharia
AU - A. Ventuneac
AU - G. Baciewicz
AU - P. V. Perumalswami
AU - S. S. Dickerson
A1 - 
AD - Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University at Buffalo, State University of New York, 875 Ellicott Street, Suite 6090, Buffalo, NY, 14203, USA. ahtalal@buffalo.edu.; Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; New York University, New York, NY, USA.; Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University at Buffalo, State University of New York, 875 Ellicott Street, Suite 6090, Buffalo, NY, 14203, USA.; START Treatment and Recovery Centers, Brooklyn, NY, USA.; University of Rochester, Rochester, NY, USA.; Division of Biobehavioral Health and Clinical Sciences, School of Nursing, University at Buffalo, Buffalo, NY, USA.
AN - 37533127
BT - Res Involv Engagem
C5 - Opioids & Substance Use; Healthcare Disparities; HIT & Telehealth; Education & Workforce
CP - 1
DA - Aug 2
DO - 10.1186/s40900-023-00474-x
DP - NLM
ET - 20230802
IS - 1
JF - Res Involv Engagem
LA - eng
PY - 2023
SN - 2056-7529
SP - 63
ST - Engaging people who use drugs in clinical research: integrating facilitated telemedicine for HCV into substance use treatment
T1 - Engaging people who use drugs in clinical research: integrating facilitated telemedicine for HCV into substance use treatment
T2 - Res Involv Engagem
TI - Engaging people who use drugs in clinical research: integrating facilitated telemedicine for HCV into substance use treatment
U1 - Opioids & Substance Use; Healthcare Disparities; HIT & Telehealth; Education & Workforce
U3 - 10.1186/s40900-023-00474-x
VL - 9
VO - 2056-7529
Y1 - 2023
ER -